Comparing robotic and video-assisted surgery for early stage lung cancer
Robotic Lobectomy vs. Thoracoscopic Lobectomy for Early Stage Lung Cancer: A Randomized Controlled Trial
This study is testing whether robotic surgery or video-assisted surgery is better for people with early stage lung cancer who need a lung operation.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 592 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | St. Joseph's Healthcare Hamilton Academic / other |
| Locations | 1 site (Hamilton, Ontario) |
| Trial ID | NCT02617186 on ClinicalTrials.gov |
What this trial studies
This clinical trial compares two minimally invasive surgical techniques for treating early stage non-small cell lung cancer: robotic thoracic surgery (RTS) and video-assisted thoracoscopic surgery (VATS). Both methods aim to improve surgical outcomes compared to traditional open surgery, but this study seeks to provide high-quality prospective data by directly comparing the two approaches. The trial will involve patients who are candidates for lobectomy, with surgeons assessing their eligibility based on clinical stage and surgical suitability. The goal is to determine which technique offers better results for patients undergoing lung resection.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with clinical stage I, II, or IIIa non-small cell lung cancer who are suitable for minimally invasive lobectomy.
Not a fit: Patients with clinical stage IIIb or IV non-small cell lung cancer or those not eligible for minimally invasive surgery may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved surgical outcomes and recovery for patients with early stage lung cancer.
How similar studies have performed: While robotic thoracic surgery has shown promise, this is one of the first studies to directly compare it with video-assisted thoracoscopic surgery in a prospective manner.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age \>/= 18 years 2. Clinical stage I, II or IIIa non-small cell lung cancer (NSCLC) 3. Candidates for minimally invasive pulmonary lobectomy, as determined by the operating surgeon. Exclusion Criteria: 1. Clinical stage IIIb or IV NSCLC 2. Not a candidate for minimally invasive surgery.
Where this trial is running
Hamilton, Ontario
- McMaster University / St. Joseph's Healthcare Hamilton — Hamilton, Ontario, Canada (Recruiting)
Study contacts
- Principal investigator: Waël C Hanna, MDCM, MBA, FRCSC — McMaster University
- Study coordinator: Yogita S Patel
- Email: patelys@mcmaster.ca
- Phone: 905-522-1155
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.